Affimed (GB:0HL9)

Affimed (0HL9) Stock Price & Analysis


0HL9 Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.65 - $3.31
Previous Close$0.89
Average Volume (3M)3.47K
Market Cap
Enterprise Value-$48.49M
Total Cash (Recent Filing)$190.29M
Total Debt (Recent Filing)$18.19M
Price to Earnings (P/E)N/A
Aug 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding149,339,335
10 Day Avg. Volume907
30 Day Avg. Volume3,467
Standard Deviation0.37
Financial Highlights & Ratios
Price to Book (P/B)0.95
Price to Sales (P/S)20.16
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.61
Enterprise Value/Gross Profit-1.17
Enterprise Value/Ebitda0.96
Price Target Upside405.05% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5




What was Affimed’s price range in the past 12 months?
Affimed lowest stock price was $0.65 and its highest was $3.31 in the past 12 months.
    What is Affimed’s market cap?
    Currently, no data Available
    When is Affimed’s upcoming earnings report date?
    Affimed’s upcoming earnings report date is Aug 09, 2023 which is in 73 days.
      How were Affimed’s earnings last quarter?
      Affimed released its earnings results on May 23, 2023. The company reported -$0.225 earnings per share for the quarter, missing the consensus estimate of -$0.206 by -$0.019.
        Is Affimed overvalued?
        According to Wall Street analysts Affimed’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Affimed pay dividends?
          Affimed does not currently pay dividends.
          What is Affimed’s EPS estimate?
          Affimed’s EPS estimate is -$0.2.
            How many shares outstanding does Affimed have?
            Currently, no data Available
            What happened to Affimed’s price movement after its last earnings report?
            Affimed reported an EPS of -$0.225 in its last earnings report, missing expectations of -$0.206. Following the earnings report the stock price went down -4.766%.
              Which hedge fund is a major shareholder of Affimed?
              Among the largest hedge funds holding Affimed’s share is Baker Bros Advisors LP. It holds Affimed’s shares valued at 5M.


                Affimed Stock Smart Score

                The Affimed Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description


                Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Mainz Biomed B.V.
                Formycon AG

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis